InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,484.49
(
0.21%
)
US TECH 100
19,401.20
(
-0.01%
)
Dow Jones
38,826.83
(
0.13%
)
Brent Oil
84.72
(
0.98%
)
Bitcoin
64,360.94
(
-3.20%
)
Post# of 3835
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gss2003

Send PM Follow Ignore
Followers 2
Posts 353
Boards Moderated 0
Alias Born 07/13/2007

gss2003

Re: biotech2010 post# 2896

Friday, 02/24/2017 12:02:48 PM

Friday, February 24, 2017 12:02:48 PM

Post# of 3835
Yes, but they can sell for access to GR-MD-02, patents and then have a secondary milestone payment if the CX trial is successive. Somewhat like NVS and TBRA.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GALT News
More GALT News
InvestorsHub NewsWire

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!